For decades, the textbook explanation for hair growth was simple: cells at the base of the follicle divide rapidly, and that division physically pushes the hair shaft upward and out, the way a plant grows from its roots. A new imaging study from L’Oréal Research & Innovation and Queen Mary University of London, published in Nature Communications, found that explanation is largely wrong — and the correction matters for anyone following hair-loss research, because it changes what a future treatment would actually need to target.
Push vs. Pull: What the Researchers Actually Tested
Using advanced 3D imaging to watch living hair follicles in real time, the team led by Dr. Inês Sequeira, Dr. Nicolas Tissot, and Dr. Thomas Bornschlögl found that cells in the outer root sheath — the follicle’s outer layer — move in a coordinated, spiral pattern that generates an upward pulling force on the hair shaft, functioning something like a microscopic motor. To test which mechanism actually drives growth, they ran two separate experiments: blocking cell division, and blocking actin (the structural protein that lets cells move and generate mechanical force).
The results were the opposite of what the old model would predict. When the researchers blocked cell division — the thing the textbook says is the actual growth engine — hair growth continued at nearly the same rate. When they blocked actin instead, disabling the cellular “motor,” growth slowed dramatically, dropping by more than 80%. In other words, the mechanical pulling mechanism turned out to matter far more than cell division itself, which is close to a reversal of the standard explanation.
Why This Isn’t Just an Academic Correction
Most hair-loss research and drug development to date has focused on the biochemical side of the follicle — hormones like DHT, growth factors, cell-signaling pathways. That’s not wrong; it’s just incomplete if a genuinely important mechanical component has been left out of the picture entirely. The researchers note that future treatments could potentially target both the biochemical and the mechanical environment of the follicle, which is a meaningfully different design space than what current minoxidil- and finasteride-based approaches work within. The new 3D imaging method itself is also a research tool, not just a finding — it gives scientists a way to test how a drug candidate affects the actual physical growth mechanism in a living follicle, rather than inferring it indirectly.
What This Does Not Mean Yet
It’s worth being precise about what this study is and isn’t. It’s a mechanistic discovery about how healthy hair growth works at a cellular level — not a new treatment, not a supplement, not something you can buy or apply. There is no product on the market today that is designed around this mechanism, and translating a finding like this into an actual therapy typically takes years of additional research: identifying which specific signals control the “motor” cells, figuring out whether that mechanism is impaired in conditions like androgenetic alopecia specifically, and then designing and testing something that safely influences it. Treat any product marketed today as leveraging this research with real skepticism — the study is only months old, and legitimate drug development doesn’t move at that speed.
How This Connects to Conditions Like Pattern Hair Loss
One open question this research raises, and doesn’t yet answer: does the “motor” mechanism weaken as a follicle miniaturizes in androgenetic alopecia, alongside the hormonal changes that are already well understood? If a shrinking follicle also loses some of its mechanical pulling capacity, that could partly explain why hairs from miniaturizing follicles are shorter and finer, not just thinner in diameter — a mechanical explanation layered on top of the biochemical one. This is a genuinely interesting hypothesis raised by the study’s implications, but it hasn’t been tested directly yet, so it belongs in the category of “worth watching” rather than “established fact.”
What to Watch For Next
The realistic timeline for a discovery like this to influence an actual treatment is measured in years, not months — first comes replication and expansion of the basic finding (do other labs see the same “motor” mechanism using different imaging methods?), then comes the harder work of figuring out which molecular signals control it, then safety and efficacy testing of anything designed to influence it, the same multi-year pipeline every hair-loss drug candidate goes through. What’s genuinely new and immediately useful about this study, separate from the treatment question, is the 3D imaging method itself — it gives researchers studying any hair-loss mechanism, hormonal or otherwise, a better tool to watch what’s actually happening inside a living follicle in real time, rather than relying on static biopsy snapshots or indirect measurements.
Frequently Asked Questions
Does this mean minoxidil and finasteride are outdated?
No. Both remain evidence-backed, FDA-approved treatments with real clinical trial data behind them, and neither is invalidated by this study. This research adds a new dimension to the science of how hair grows — it doesn’t undo the biochemical mechanisms those medications already target.
Is there a product based on this research I can buy?
Not yet, and be skeptical of anything marketed that way. This is foundational biology research published in 2025/2026; a consumer product genuinely built around it is realistically years away, if it happens at all.
Where can I read the actual study?
It was published in Nature Communications and is available through the journal’s open-access system, with independent science coverage from outlets including ScienceDaily and Queen Mary University’s own newsroom.
Why did a cosmetics company co-fund this research?
L’Oréal runs a substantial internal research division that publishes in peer-reviewed journals like any academic lab, and hair-growth biology is directly relevant to a company that sells hair-care products. That commercial connection is worth noting for transparency, but it doesn’t change the fact that the findings were peer-reviewed and published through the same process as independently funded research, alongside an academic co-author team at Queen Mary University of London.
Final Thoughts
This is the kind of study that won’t change anything about your hair-care routine tomorrow, but it’s a genuine shift in the basic science — and basic science shifts like this are usually where the next generation of treatments eventually comes from, even if it takes years to get there.
For grounded coverage of hair-loss research as it develops, keep following the Hair Care section on gemifys.com.
